1. Home
  2. Healthcare
  3. global-lymphedema-treatment-market
Image

Global Lymphedema Treatment Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 619
  • No of Figures: 77
  • Healthcare
  • Published Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 619
  • No of Figures: 77

Global Lymphedema Treatment Market, By Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy and Others), Type (Primary Lymphedema and Secondary Lymphedema), Affected Area (Genital, Lower Extremity, Upper Extremity and Others), Age Group (Adult and Geriatric), Route of Administration (Oral, Injectable and Others), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics and Others), Distribution Channel (Direct Tender, Pharmacy Stores, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, and  Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines , Vietnam, and Rest of Asia-Pacific, Brazil, Argentina , Peru, and Rest of South America, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, and Rest of Middle East and Africa)  Industry Trends and Forecast to 2029

Lymphedema Treatment Market Market Analysis and Insights: Global Lymphedema Treatment Market

Global lymphedema treatment market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the global lymphedema treatment market is growing with a CAGR of 9.2% in the forecast period of 2022 to 2029 and is expected to reach USD 1,671.51 million by 2029 from USD 841.00 million in 2022. Rising healthcare expenditure and escalation in innovation and technologies are major drivers which are expected to the growth of the market in the forecast period.

Lymphedema refers to swelling that generally occurs in upper and lower extremities. Sometimes both arms and both legs swell. Lymphedema is most commonly caused by the removal of or damage to lymph nodes as a part of cancer treatment. It results from a blockage in lymphatic system, which is part of immune system. Stems from a damaged lymphatic system, can lead to infections, disfigurement, debilitating pain and disability. There is no cure for lymphedema.

Lymphedema treatment involves multiple therapies instead of standard treatment, since the patients are dissatisfied or don’t get cured with the conventional treatment of lymphedema. They approach the alternative treatment which offers more control over health care decisions, and the alternatives are found to be more compatible with the patient’s health system.

Lymphedema can occur after any cancer or its treatment that affects lymph node drainage. It has been reported to occur within days and up to 30 years after treatment for breast cancer. The initial stage lymphedema treatments are therapies, surgeries and lymphovenous transplant among others. But there is no permanent cure for lymphedema.

A growing number of people are affected with by the lymphedema treatment which demand highly effective and advanced treatment to minimize the risk during the treatment. The healthcare systems need highly advanced treatment products. Therefore, the major market players are highly focusing on product launches and product approvals. Additionally, the government and regulatory bodies are supporting market players by virtue of product approval.

The increase research & development investment for drug discovery and increasing in health expenditure have accelerated the need for in healthcare facilities. The surging volume of Lymphedema treatment   patients along with the rising prevalence of Lymphedema treatment is also propelling the growth of the market

High cost of surgeries and liposuction and adverse side-effects associated with treatment are anticipated to hinder market growth in the projected period.

Strategic initiatives by the market players, increasing healthcare expenditure, rising R & D activities act as an opportunity for this market and is expected to impel the market growth.

No permanent cure of the disease and lack of reimbursement is a challenge for this market.

The global lymphedema treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Lymphedema Treatment Market Global Lymphedema Treatment Market Scope and Market Size

The global lymphedema treatment market is segmented on the basis of treatment type, type, affected area, age group, route of administration, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of treatment type, the global lymphedema treatment market is segmented into compression therapy, surgery, drug therapy, laser therapy and others. In 2022, compression therapy segment is expected to dominate the market as this effectively manages the disease symptoms.

  • On the basis of type, the global lymphedema treatment market is segmented into secondary lymphedema and primary lymphedema. In 2022, secondary lymphedema segment is expected to dominate the market because secondary is the most common lymphedema among the population.

  • On the basis of affected area, the global lymphedema treatment market is segmented into lower extremity, upper extremity and genitalia. In 2022, lower extremity segment is expected to dominate the market because lower extremities is found to be mostly affected in case of lymphedema.

  • On the basis of age group, the global lymphedema treatment market is segmented into adult, geriatric and pediatric. In 2022, adult segment is expected to dominate the market because secondary is the most common lymphedema among the population.

  • On the basis of route of administration, the global Lymphedema treatment market is segmented into oral, injectable and topical. In 2022, oral segment expected to dominate the market because it is most effective mode administration with better patient compliance.

  • On the basis of end user, the global lymphedema treatment market is segmented into hospital, speciality clinics, ambulatory surgical centers and others. In 2022, hospitals segment is expected to dominate the market because of surging pool of lymphedema treatment patients.

  • On the basis of distribution channel, the global lymphedema treatment market is segmented into pharmacy stores, direct tender and others. In 2022, segmented pharmacy stores segment is expected to dominate the market owing to the rising among the target population and increasing R & D activities.

Lymphedema Treatment Market Global Lymphedema Treatment Market Country Level Analysis

The global lymphedema treatment market is analyzed and market size information is provided based treatment type, type, affected area, age group, route of administration, end user, and distribution channel

Countries covered in the global lymphedema treatment market report are North America, Europe, Asia-Pacific, South America and Middle East and Africa. These regions are further segmented into major countries such as the U.S., Canada, Mexico, Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, rest Of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest Of Asia-Pacific, Brazil, Argentina, Peru, rest Of South America, Saudi Arabia, South Africa, UAE, Egypt, Kuwait, Israel, and rest Of Middle East and Africa.

North America is expected to dominate the global lymphedema treatment market due to rising technological advancement in the region and Asia-Pacific is expected to grow with the highest CAGR in the forecast period due to increasing healthcare expenditure in the region. The U.S. is dominating in the market and leading the growth in the global lymphedema treatment market due to rising awareness IgG4-related disease. The Asia-Pacific region is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 because of rising. China is dominating Asia-Pacific market due to rising disposable income in the country. The market in Europe is expected to grow significantly in the forecast period of 2021 to 2028 due to technological advancements in the region. Germany is dominating the European market owing to large number of players in the market.

Lymphedema treatment by disease type segment in the U.S. is expected to grow with the highest rate and it is dominating the North America region in the forecast period of 2022 to 2029 because of rising innovation and technologies. Germany is leading the market in Europe region and lymphedema treatment compression therapy segment is dominating the country due to rising prevalence of cancer cases. In addition, compression therapy segment is dominating in China, which is leading in the Asia-Pacific region owing to surging population lymphedema patients in China for the treatment of lymphedema in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

Rising healthcare expenditure and escalation in innovations and technologies in the global lymphedema treatment market are creating new opportunities for players in the global lymphedema treatment market

Global lymphedema treatment market also provides you with detailed market analysis for every country growth in particular industry with the global Lymphedema treatment market sales, impact of advancement in the global lymphedema treatment market and changes in regulatory scenarios with their support for the global Lymphedema treatment market. The data is available for historic period 2020 to 2029. 

Competitive Landscape and Global Lymphedema Treatment Market Share Analysis

Global Lymphedema treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to global Lymphedema treatment market.

Major players covered in the report are are medi GmbH & Co. KG, PAUL HARTMANN AG, 3M, Convatec Inc., JUZO, SIGVARIS GROUP, Sanyleg Srl a socio unico, AIROS Medical, Inc., Tactile Medical, BIOCOMPRESSION SYSTEMS, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd.,  ThermoTek, Cardinal Health, Essity (BSN medical GmbH), Smith+Nephew HERANTIS PHARMA Plc, Huntleigh Healthcare Limited, Avet Pharmaceuticals Inc, and KOYA MEDICAL among others domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the global Lymphedema treatment market.

For instance,

  • In August 2021, AIROS Medical, fist assist devices announced exclusive U.S. distribution deal for fist assist fa-1 compression device. This partnership will boost the market growth of the company.

  • In September 2020, Paul Hartmann formed partnerships with Apollo Hospitals Group in India and West China Hospital in to focus on the operation of wound care clinics and ambulances, medical training and products and services. This step helped the company to spread its wings in Asia Pacific market.

SKU-
Advance Formative Research Customization
Request for bulk
Reports
Why Choose Us


Frequently Asked Questions

Lymphedema Treatment Market is growing with a CAGR of 9.2% during the forecast period of 2022 to 2029.
Lymphedema Treatment Market is expected to reach USD 1,671.51 million during the forecast period of 2022 to 2029.
The global lymphedema treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
Major players covered in the report are are medi GmbH & Co. KG, PAUL HARTMANN AG, 3M, Convatec Inc., JUZO, SIGVARIS GROUP, Sanyleg Srl a socio unico, AIROS Medical, Inc., Tactile Medical, BIOCOMPRESSION SYSTEMS, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd.,  ThermoTek, Cardinal Health, Essity (BSN medical GmbH), Smith+Nephew HERANTIS PHARMA Plc, Huntleigh Healthcare Limited, Avet Pharmaceuticals Inc, and KOYA MEDICAL among others domestic and global players.

Browse Related Reports

Europe Lymphedema Treatment Market – Industry Trends and Forecast to 2029

Middle East and Africa Lymphedema Treatment Market – Industry Trends and Forecast to 2029

Asia-Pacific Lymphedema Treatment Market – Industry Trends and Forecast to 2029

North America Lymphedema Treatment Market – Industry Trends and Forecast to 2029


Browse Related Blogs

Global Lymphedema Treatment Market is Growing with a CAGR of 9.2% in the Forecast Period of 2022 to 2029


Browse Related Press Release

In 2020, the Pooled Prevalence of Arm Lymphedema was 27%, with Considerable Heterogeneity

Tactile Medical, 3M, and Essity (BSN medical GmbH) dominated the North America Lymphedema Treatment Market in 2021


REPORTS

MARKET INSIGHT

SUPPORT

SOLUTIONS

DMCA Protected © DataBridge - All Rights Reserved.